| Detected | Trial | Change |
|---|---|---|
| 2026-07-19 | NCT03986034 Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic… |
date change Primary completion pushed: 2026-07-03 -> 2026-11-17 |
| 2026-07-19 | NCT03986034 Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic… |
date change Completion pushed: 2026-07-03 -> 2026-11-17 |
| 2026-07-16 | NCT04216342 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers |
date change Primary completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-07-16 | NCT04216342 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers |
date change Completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-07-16 | NCT03685721 Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase… |
date change Primary completion pushed: 2026-07-01 -> 2027-07-01 |
| 2026-07-16 | NCT03685721 Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase… |
date change Completion pushed: 2026-07-01 -> 2027-07-01 |
| 2026-07-16 | NCT02417714 Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR) |
date change Primary completion pushed: 2026-06-30 -> 2026-09-22 |
| 2026-07-16 | NCT02417714 Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR) |
date change Completion pushed: 2026-07-01 -> 2026-09-22 |
| 2026-07-16 | NCT05998408 JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure |
Primary endpoint(s) modified |
| 2026-07-15 | NCT06093867 Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic… |
date change Primary completion pushed: 2026-10-01 -> 2028-10-01 |
| 2026-07-15 | NCT06093867 Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic… |
date change Completion pushed: 2029-10-01 -> 2030-10-01 |
| 2026-07-15 | NCT07613099 Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation… |
Recruitment opened |
| 2026-07-07 | NCT00071045 Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and… |
overall status: "Recruiting" → "Enrolling By Invitation" |
| 2026-07-03 | NCT05170399 Vaccine Responses in Patients With B Cell Malignancies |
Enrollment reduced: 500 -> 350 participants |
| 2026-06-26 | NCT03312400 Low-Dose Danazol for the Treatment of Telomere Related Diseases |
Trial completed |
| 2026-06-26 | NCT03312400 Low-Dose Danazol for the Treatment of Telomere Related Diseases |
date change Primary completion moved earlier: 2027-04-29 -> 2025-10-31 |
| 2026-06-26 | NCT03312400 Low-Dose Danazol for the Treatment of Telomere Related Diseases |
date change Completion moved earlier: 2027-10-29 -> 2025-10-31 |
| 2026-06-23 | NCT07566494 Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease |
overall status: "Enrolling By Invitation" → "Recruiting" |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05170399 | Vaccine Responses in Patients With B Cell Malignancies | Lymphoma | Recruiting |
| Phase 3 | |||
| NCT07613099 | Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation… | Allogeneic Stem Cell Transplantation | Recruiting |
| Phase 2 | |||
| NCT04304820 | Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive… | Severe Aplastic Anemia | Recruiting |
| NCT03372733 | Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults | Cardiovascular Disease | Recruiting |
| NCT06923072 | Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological… | Kohlmeier-Degos Disease | Recruiting |
| NCT01174108 | Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other… | Severe Aplastic Anemia | Recruiting |
| NCT03520647 | Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH… | Severe Aplastic Anemia (SAA) | Recruiting |
| NCT03986034 | Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT02979873 | Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia… | Severe Aplastic Anemia | Active, Not Recruiting |
| NCT02514083 | A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLL | Chronic Lymphocytic Leukemia | Active, Not Recruiting |
| NCT01500733 | PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | Leukemia | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT04008368 | Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease… | Myeloid Chimerism | Recruiting |
| NCT01799538 | Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis | Lymphangioleiomyomatosis | Recruiting |
| NCT03173937 | Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and… | Severe Aplastic Anemia | Recruiting |
| NCT06032923 | Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With… | Systemic Lupus Erythematosus (Sle) | Recruiting |
| NCT07599176 | Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors | Sickle Cell Disease | Recruiting |
| NCT05357482 | Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell… | Sickle Cell Anemia | Active, Not Recruiting |
| NCT01623167 | Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia | Severe Aplastic Anemia | Active, Not Recruiting |
| NCT00977691 | Haploidentical PBMC Transplant for Severe Congenital Anemias | Sickle Cell Anemia | Active, Not Recruiting |
| NCT03077542 | Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell… | Sickle Cell Disease | Active, Not Recruiting |
| NCT06145282 | Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease… | Sickle Cell Disease | Active, Not Recruiting |
| NCT04610866 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat… | Sickle Cell Disease | Active, Not Recruiting |
| NCT05998408 | JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure | Severe Aplastic Anemia | Active, Not Recruiting |
| Phase 1 | |||
| NCT05967299 | Study of Intravenous ZMA001 in Healthy Subjects | Pulmonary Arterial Hypertension PAH | Recruiting |
| NCT05904093 | Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in… | Sickle Cell Disease | Recruiting |